ProfileGDS4459 / ENSG00000143653
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 98% 96% 94% 98% 97% 98% 97% 97% 97% 96% 96% 97% 96% 98% 97% 96% 97% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 19.0998
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 28.5596
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.0994
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 48.9698
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 58.8697
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 69.2398
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.7497
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 88.8897
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 98.8997
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 108.6296
GSM623474group B, liver allograft wedge biopsie placebo treatment 18.6396
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.8597
GSM623476group B, liver allograft wedge biopsie placebo treatment 38.4396
GSM623477group B, liver allograft wedge biopsie placebo treatment 49.4398
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.8197
GSM623479group B, liver allograft wedge biopsie placebo treatment 68.6796
GSM623480group B, liver allograft wedge biopsie placebo treatment 78.7397